CGON – cg oncology, inc. (US:NASDAQ)
Stock Stats
News
CG Oncology, Inc. (NASDAQ: CGON) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $50.00 price target on the stock.
CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates
CG Oncology: ASCO Play And Top-Line Data End Of 2024 Could Drive Further Value [Seeking Alpha]
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Form 4 CG Oncology, Inc. For: May 15 Filed by: Patterson Joshua F.
Form 3 CG Oncology, Inc. For: May 13 Filed by: Patterson Joshua F.
Form 8-K CG Oncology, Inc. For: May 09
Form 10-Q CG Oncology, Inc. For: Mar 31
Form 8-K CG Oncology, Inc. For: May 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.